BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 21641967)

  • 1. Genetic susceptibility to sporadic ovarian cancer: a systematic review.
    Braem MG; Schouten LJ; Peeters PH; van den Brandt PA; Onland-Moret NC
    Biochim Biophys Acta; 2011 Dec; 1816(2):132-46. PubMed ID: 21641967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between gene expression variations and ovarian cancer risk alleles identified from genome wide association studies.
    Zhao H; Shen J; Wang D; Guo Y; Gregory S; Medico L; Hu Q; Yan L; Odunsi K; Lele S; Liu S
    PLoS One; 2012; 7(11):e47962. PubMed ID: 23133607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.
    Goode EL; Chenevix-Trench G; Song H; Ramus SJ; Notaridou M; Lawrenson K; Widschwendter M; Vierkant RA; Larson MC; Kjaer SK; Birrer MJ; Berchuck A; Schildkraut J; Tomlinson I; Kiemeney LA; Cook LS; Gronwald J; Garcia-Closas M; Gore ME; Campbell I; Whittemore AS; Sutphen R; Phelan C; Anton-Culver H; Pearce CL; Lambrechts D; Rossing MA; Chang-Claude J; Moysich KB; Goodman MT; Dörk T; Nevanlinna H; Ness RB; Rafnar T; Hogdall C; Hogdall E; Fridley BL; Cunningham JM; Sieh W; McGuire V; Godwin AK; Cramer DW; Hernandez D; Levine D; Lu K; Iversen ES; Palmieri RT; Houlston R; van Altena AM; Aben KK; Massuger LF; Brooks-Wilson A; Kelemen LE; Le ND; Jakubowska A; Lubinski J; Medrek K; Stafford A; Easton DF; Tyrer J; Bolton KL; Harrington P; Eccles D; Chen A; Molina AN; Davila BN; Arango H; Tsai YY; Chen Z; Risch HA; McLaughlin J; Narod SA; Ziogas A; Brewster W; Gentry-Maharaj A; Menon U; Wu AH; Stram DO; Pike MC; ; Beesley J; Webb PM; ; ; ; Chen X; Ekici AB; Thiel FC; Beckmann MW; Yang H; Wentzensen N; Lissowska J; Fasching PA; Despierre E; Amant F; Vergote I; Doherty J; Hein R; Wang-Gohrke S; Lurie G; Carney ME; Thompson PJ; Runnebaum I; Hillemanns P; Dürst M; Antonenkova N; Bogdanova N; Leminen A; Butzow R; Heikkinen T; Stefansson K; Sulem P; Besenbacher S; Sellers TA; Gayther SA; Pharoah PD;
    Nat Genet; 2010 Oct; 42(10):874-9. PubMed ID: 20852632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional Analysis and Fine Mapping of the 9p22.2 Ovarian Cancer Susceptibility Locus.
    Buckley MA; Woods NT; Tyrer JP; Mendoza-Fandiño G; Lawrenson K; Hazelett DJ; Najafabadi HS; Gjyshi A; Carvalho RS; Lyra PC; Coetzee SG; Shen HC; Yang AW; Earp MA; Yoder SJ; Risch H; Chenevix-Trench G; Ramus SJ; Phelan CM; Coetzee GA; Noushmehr H; Hughes TR; Sellers TA; Goode EL; Pharoah PD; Gayther SA; Monteiro ANA;
    Cancer Res; 2019 Feb; 79(3):467-481. PubMed ID: 30487138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of microRNA expression profiles and their associations with risk alleles in lymphoblastoid cell lines of familial ovarian cancer.
    Shen J; Wang D; Gregory SR; Medico L; Hu Q; Yan L; Odunsi K; Lele SB; Ambrosone CB; Liu S; Zhao H
    Carcinogenesis; 2012 Mar; 33(3):604-12. PubMed ID: 22235027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of common genetic variants in ovarian cancer susceptibility and outcome: progress to date from the Ovarian Cancer Association Consortium (OCAC).
    Bolton KL; Ganda C; Berchuck A; Pharaoh PD; Gayther SA
    J Intern Med; 2012 Apr; 271(4):366-78. PubMed ID: 22443200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common variants in RB1 gene and risk of invasive ovarian cancer.
    Song H; Ramus SJ; Shadforth D; Quaye L; Kjaer SK; Dicioccio RA; Dunning AM; Hogdall E; Hogdall C; Whittemore AS; McGuire V; Lesueur F; Easton DF; Jacobs IJ; Ponder BA; Gayther SA; Pharoah PD
    Cancer Res; 2006 Oct; 66(20):10220-6. PubMed ID: 17047088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common variants in mismatch repair genes and risk of invasive ovarian cancer.
    Song H; Ramus SJ; Quaye L; DiCioccio RA; Tyrer J; Lomas E; Shadforth D; Hogdall E; Hogdall C; McGuire V; Whittemore AS; Easton DF; Ponder BA; Kjaer SK; Pharoah PD; Gayther SA
    Carcinogenesis; 2006 Nov; 27(11):2235-42. PubMed ID: 16774946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rethinking ovarian cancer genomics: where genome-wide association studies stand?
    Pinto R; Assis J; Nogueira A; Pereira C; Pereira D; Medeiros R
    Pharmacogenomics; 2017 Nov; 18(17):1611-1625. PubMed ID: 29095100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study.
    Lee AW; Tyrer JP; Doherty JA; Stram DA; Kupryjanczyk J; Dansonka-Mieszkowska A; Plisiecka-Halasa J; Spiewankiewicz B; Myers EJ; ; ; Chenevix-Trench G; Fasching PA; Beckmann MW; Ekici AB; Hein A; Vergote I; Van Nieuwenhuysen E; Lambrechts D; Wicklund KG; Eilber U; Wang-Gohrke S; Chang-Claude J; Rudolph A; Sucheston-Campbell L; Odunsi K; Moysich KB; Shvetsov YB; Thompson PJ; Goodman MT; Wilkens LR; Dörk T; Hillemanns P; Dürst M; Runnebaum IB; Bogdanova N; Pelttari LM; Nevanlinna H; Leminen A; Edwards RP; Kelley JL; Harter P; Schwaab I; Heitz F; du Bois A; Orsulic S; Lester J; Walsh C; Karlan BY; Hogdall E; Kjaer SK; Jensen A; Vierkant RA; Cunningham JM; Goode EL; Fridley BL; Southey MC; Giles GG; Bruinsma F; Wu X; Hildebrandt MA; Lu K; Liang D; Bisogna M; Levine DA; Weber RP; Schildkraut JM; Iversen ES; Berchuck A; Terry KL; Cramer DW; Tworoger SS; Poole EM; Olson SH; Orlow I; Bandera EV; Bjorge L; Tangen IL; Salvesen HB; Krakstad C; Massuger LF; Kiemeney LA; Aben KK; van Altena AM; Bean Y; Pejovic T; Kellar M; Le ND; Cook LS; Kelemen LE; Brooks-Wilson A; Lubinski J; Gronwald J; Cybulski C; Jakubowska A; Wentzensen N; Brinton LA; Lissowska J; Yang H; Nedergaard L; Lundvall L; Hogdall C; Song H; Campbell IG; Eccles D; Glasspool R; Siddiqui N; Carty K; Paul J; McNeish IA; Sieh W; McGuire V; Rothstein JH; Whittemore AS; McLaughlin JR; Risch HA; Phelan CM; Anton-Culver H; Ziogas A; Menon U; Ramus SJ; Gentry-Maharaj A; Harrington P; Pike MC; Modugno F; Rossing MA; Ness RB; Pharoah PD; Stram DO; Wu AH; Pearce CL
    Gynecol Oncol; 2015 Mar; 136(3):542-8. PubMed ID: 25528498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review of replication studies of prostate cancer susceptibility genetic variants in high-risk men originally identified from genome-wide association studies.
    Ishak MB; Giri VN
    Cancer Epidemiol Biomarkers Prev; 2011 Aug; 20(8):1599-610. PubMed ID: 21715604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tagging single nucleotide polymorphisms in the BRIP1 gene and susceptibility to breast and ovarian cancer.
    Song H; Ramus SJ; Kjaer SK; Hogdall E; Dicioccio RA; Whittemore AS; McGuire V; Hogdall C; Jacobs IJ; Easton DF; Ponder BA; Dunning AM; Gayther SA; Pharoah PD
    PLoS One; 2007 Mar; 2(3):e268. PubMed ID: 17342202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host genetic susceptibility to oral cancer: evidence from meta-analyses and pooled analyses.
    Liao G; Wang Y; Zhou YQ; Li TW; Zeng DQ; Zeng X; Li J; Dan HX; Chen QM
    Oral Dis; 2014 Oct; 20(7):644-9. PubMed ID: 24102947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial vezatin and its association with endometriosis risk.
    Holdsworth-Carson SJ; Fung JN; Luong HT; Sapkota Y; Bowdler LM; Wallace L; Teh WT; Powell JE; Girling JE; Healey M; Montgomery GW; Rogers PA
    Hum Reprod; 2016 May; 31(5):999-1013. PubMed ID: 27005890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variants in telomere-maintenance genes are associated with ovarian cancer risk and outcome.
    Sun Y; Tao W; Huang M; Wu X; Gu J
    J Cell Mol Med; 2017 Mar; 21(3):510-518. PubMed ID: 28233473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian cancer survival and polymorphisms in hormone and DNA repair pathway genes.
    Nagle CM; Chenevix-Trench G; Webb PM; Spurdle AB
    Cancer Lett; 2007 Jun; 251(1):96-104. PubMed ID: 17182175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prostate cancer risk locus at 10q11 is associated with DNA repair capacity.
    Rinckleb AE; Surowy HM; Luedeke M; Varga D; Schrader M; Hoegel J; Vogel W; Maier C
    DNA Repair (Amst); 2012 Aug; 11(8):693-701. PubMed ID: 22677538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphisms and lung cancer risk: Evidence from meta-analyses and genome-wide association studies.
    Liu C; Cui H; Gu D; Zhang M; Fang Y; Chen S; Tang M; Zhang B; Chen H
    Lung Cancer; 2017 Nov; 113():18-29. PubMed ID: 29110844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
    Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
    BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive gene-environment interaction analysis in Ovarian Cancer using genome-wide significant common variants.
    Kim S; Wang M; Tyrer JP; Jensen A; Wiensch A; Liu G; Lee AW; Ness RB; Salvatore M; Tworoger SS; Whittemore AS; Anton-Culver H; Sieh W; Olson SH; Berchuck A; Goode EL; Goodman MT; Doherty JA; Chenevix-Trench G; Rossing MA; Webb PM; Giles GG; Terry KL; Ziogas A; Fortner RT; Menon U; Gayther SA; Wu AH; Song H; Brooks-Wilson A; Bandera EV; Cook LS; Cramer DW; Milne RL; Winham SJ; Kjaer SK; Modugno F; Thompson PJ; Chang-Claude J; Harris HR; Schildkraut JM; Le ND; Wentzensen N; Trabert B; Høgdall E; Huntsman D; Pike MC; Pharoah PDP; Pearce CL; Mukherjee B
    Int J Cancer; 2019 May; 144(9):2192-2205. PubMed ID: 30499236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.